Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/301% above fair value
$100.61−0.11 (-0.11%)
Close on Nov 19, 2026Market cap $128.69BP/E 24.7Yield 2.82%
Medtronic free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Medtronic's free cash flow for the twelve months ending Jul 31, 2026 was $6.13B, up 15.6% year over year. For fiscal 2026 it was $5.43B, up 4.6% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $6.02B in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $5.43B | +4.6% |
| FY2025 | Apr 25, 2025 | $5.19B | -0.3% |
| FY2024 | Apr 26, 2024 | $5.20B | +13.5% |
| FY2023 | Apr 28, 2023 | $4.58B | -23.4% |
| FY2022 | Apr 29, 2022 | $5.98B | +22.4% |
| FY2021 | Apr 30, 2021 | $4.89B | -18.9% |
| FY2020 | Apr 24, 2020 | $6.02B | +2.5% |
| FY2019 | Apr 26, 2019 | $5.87B | +62.4% |
| FY2018 | Apr 27, 2018 | $3.62B | -35.7% |
| FY2017 | Apr 28, 2017 | $5.63B | +34.9% |
| FY2016 | Apr 29, 2016 | $4.17B | -3.7% |
| FY2015 | Apr 24, 2015 | $4.33B | -5.1% |
| FY2014 | Apr 25, 2014 | $4.56B | +1.7% |
| FY2013 | Apr 26, 2013 | $4.49B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $1.29B | +120.9% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $2.09B | +0.8% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $2.30B | +9.7% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $457.00M | -17.5% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $584.00M | +25.3% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $2.07B | -12.0% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $2.10B | -1.5% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $554.00M | +177.0% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $466.00M | -10.6% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $2.35B | +12.9% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $2.13B | +71.3% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $200.00M | -66.6% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $521.00M | -20.7% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $2.08B | +24.8% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $1.24B | -34.6% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $599.00M | -60.0% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $657.00M | -28.1% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $1.67B | +21.9% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $1.90B | -4.8% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $1.50B | -5.2% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $914.00M | – |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.37B | +22.8% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $1.99B | -5.7% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $1.58B | -0.3% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | -$56.00M | -104.6% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $1.11B | -36.4% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $2.11B | +20.6% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $1.58B | +65.5% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $1.21B | -14.3% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $1.75B | +134.9% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $1.75B | +0.2% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $957.00M | +44.8% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $1.41B | +207.4% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $746.00M | -48.3% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $1.75B | -0.5% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $661.00M | -45.1% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $459.00M | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $1.44B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $1.76B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $1.20B | – |
See a number that looks wrong?